Sorrento Therapeutics

+$0.10 (+6.94%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRNE and other ETFs, options, and stocks.

About SRNE

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates.

CEO
Henry H. Ji
Employees
799
Headquarters
San Diego, California
Founded
1989

SRNE Key Statistics

Market cap
598.98M
Price-Earnings ratio
—
Dividend yield
—
Average volume
7.80M
High today
$1.57
Low today
$1.41
Open price
$1.43
Volume
5.62M
52 Week high
$11.07
52 Week low
$1.15

SRNE Earnings

-$0.57
-$0.30
-$0.03
$0.24
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure